Table 6 The relationship between mGPS, NLS and 5 year cancer specific survival (CSS) and overall survival (OS) rates in patients undergoing potentially curative resection of TNM stage II (n = 137) and III (n = 140) rectal cancer.
mGPS 0 | mGPS 1/2 | mGPS 0–2 | mGPS 0 | mGPS 1/2 | mGPS 0–2 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | 5 year CSS % (SE) | n | 5 year CSS % (SE) | n | 5 year CSS (%) | n | 5 year OS % (SE) | n | 5 year OS % (SE) | n | 5 year OS % (SE) | |
NPS 0 | 83 (89%) | 77.1 (0.05) | 32 (73%) | 75.0 (0.08) | 115 | 76.5 (0.04) | 83 (89%) | 63.9 (0.05) | 32 (73%) | 56.3 (0.09) | 115 | 61.7 (0.05) |
NPS 1/2 | 10 (11%) | 70.0 (0.15) | 12 (27%) | 50.0 (0.15) | 22 | 59.1 (0.11) | 10 (11%) | 30.0 (0.15) | 12 (27%) | 16.7 (0.11) | 22 | 22.7 (0.09) |
NPS 0–2 | 93 | 76.3 (0.04) | 44 | 68.2 (0.07) | 137 | 73.7 (0.04) | 93 | 60.2 (0.05) | 44 | 45.5 (0.08) | 137 | 55.5 (0.04) |
Stage III (n = 140) | Stage III (n = 140) | |||||||||||
NPS 0 | 106 (93%) | 70.8 (0.04) | 18 (69%) | 66.7 (0.11) | 124 | 70.2 (0.04) | 106 (93%) | 57.5 (0.05) | 18 (69%) | 44.4 (0.12) | 124 | 55.6 (0.05) |
NPS 1/2 | 8 (7%) | 75.0 (0.16) | 8 (31%) | 37.5 (0.18) | 16 | 56.3 (0.13) | 8 (7%) | 37.5 (0.18) | 8 (31%) | 25.0 (0.16) | 16 | 31.3 (0.12) |
NPS 0–2 | 114 | 71.1 (0.04) | 26 | 57.7 (0.10) | 140 | 68.6 (0.04) | 114 | 56.1 (0.05) | 26 | 38.5 (0.10) | 140 | 52.9 (0.04) |
